Journal
MICROCHIMICA ACTA
Volume 188, Issue 9, Pages -Publisher
SPRINGER WIEN
DOI: 10.1007/s00604-021-04959-y
Keywords
Glycated hemoglobin; Electrochemiluminescence; Metal organic framework; Nanocluster; Gold nanocluster; Paper-based electrode; Screen-printed electrode; Cyclic voltammetry
Categories
Funding
- Endocrinology and Metabolism Research Center of Tehran University of Medical Sciences in Iran
Ask authors/readers for more resources
An immunosensor using a sandwich paper-based electrochemiluminescence (ECL) biosensor for detecting glycated hemoglobin has been developed, demonstrating desirable assay performance with a wide response range and low detection limit.
Glycated hemoglobin (HbA1c) is one of the most popular biomarkers which can be utilized for the diagnosis and control of diabetes in clinical practice. In this study, a sandwich paper-based electrochemiluminescence (ECL) biosensor has been developed using the zirconium metal-organic framework/Fe3O4(trimethyl chitosan)/gold nanocluster (Zr-MOF/Fe3O4(TMC)/AuNCs) nanocomposite as tracing tag to label anti-HbA1c monoclonal antibody and reduced graphene oxide (rGO) as immobilization platform of sensing element. The screen-printed electrodes (SPEs) were constructed and modified by sputtering a thick layer of gold on the paper substrate, followed by electrochemical reduction of aminophenylboronic acid (APBA)-functionalized GO to rGO/APBA, respectively. Different types of surface analysis methods were applied to characterize the Zr-MOF/Fe3O4(TMC)/AuNCs nanomaterials fabricated. Finally, antibody-labeled Zr-MOF/Fe3O4(TMC)/AuNCs nanocomposites were subjected to HbA1c in the sample and on the paper-based SPE. Quantitative measurement of HbA1c was performed using ECL and cyclic voltammetry (CV) over a potential range of - 0.2 to 1.7 V vs gold reference electrode with a sweep rate of 0.2 V.s(-1) in the presence of triethylamine as a co-reactant after sandwiching the HbA1c target between antibody and APBA on the sensing area. This immunosensor demonstrated the desirable assay performance for HbA1c with a wide response range from 2 to 18% and a low detection limit (0.072%). This new strategy provides an effective method for high-performance bioanalysis and opens avenues for the development of high-sensitive and user-friendly device. Graphical abstract
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available